Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	16931
Country	Israel

Received	2015-02-04 09:24
Peer-Review Started	2015-02-04 16:54
To Make the First Decision	2015-03-20 11:40
Return for Revision	2015-03-28 15:19
Revised	2015-04-01 10:38
Second Decision	2015-04-20 11:48
Accepted by Journal Editor-in-Chief	2015-04-22 04:05
Accepted by Executive Editor-in-Chief	2015-04-30 11:36
Articles in Press	2015-04-30 11:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-23 12:31
Publish the Manuscript Online	2015-08-17 16:11

ISSN	2150-5330 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Human microbiome: From the bathroom to the bedside
Manuscript Source	Invited Manuscript
All Author List	Stephen Malnick and Ehud Melzer
Funding Agency and Grant Number
Corresponding Author	Stephen Malnick, MA (Oxon), MSc, MBBS (Lond), Director, Department of Internal Medicine C, Kaplan Medical Center, Affiliated to the Hebrew University, Jerusalem, Rehovot 76100, Israel. stephen@malnick.net
Key Words	Fecal microbial transplant; Clostridium difficile; Side-effects; Indications; Metabolic disorders
Core Tip	Fecal microbial transplantation is approved for the treatment of recurrent Clostridium difficile infection by either nasojejunal administration or colonoscopy. In addition there is some evidence for its use in both irritable bowel syndrome and inflammatory bowel disease. There are, however, reports of side effects including weight gain, diverticulitis and development of autoimmune disease. Treatment for non-approved conditions should be performed in the framework of clinical research trials in order to better define the indications.
Publish Date	2015-08-17 16:11
Citation	Malnick S, Melzer E. Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol 2015; 6(3): 79-85
URL	http://www.wjgnet.com/2150-5330/full/v6/i3/79.htm
DOI	http://dx.doi.org/10.4291/wjgp.v6.i3.79

Full Article (PDF)	WJGP-6-79.pdf
Full Article (Word)	WJGP-6-79.doc
Manuscript File	16931-Review.docx
Answering Reviewers	16931-Answering reviewers.pdf
Audio Core Tip	16931-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	16931-Conflict-of-interest statement.pdf
Copyright License Agreement	16931-Copyright assignment.pdf
Peer-review Report	16931-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16931-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16931-Scientific misconduct check.pdf
Scientific Editor Work List	16931-Scientific editor work list.pdf